Journal of the Dermatology Nurses' Association

October 2009, Volume 1 Number 5 , p 293 - 293 [FREE]


  • Melodie S. Young MSN, RN, ANP-C


function set_JnlFullText_Print() { metaTag = document.createElement('meta'); metaTag.setAttribute('name','OvidPageId'); metaTag.setAttribute('content','JnlFullText_Print'); head = document.getElementsByTagName('head')[0]; head.appendChild(metaTag); return; } if (window.addEventListener) { // DOM Level 2 Event Module (NS 6+) // Firefox throws an uncaught exception error executing this // code, even though it seems to work. Adding a do nothing // try/catch clause around it for now, since the exection itself // appears to be innocuous try { window.addEventListener('onload',set_JnlFullText_Print(),false); } catch(e) {} } else if (window.attachEvent) { // IE 5+ Event Model window.attachEvent('onload',set_JnlFullText_Print); } // For anything else, just don't add the event Print Close Journal of the Dermatology Nurses' Association Re: U.S. Food and Drug Administration (FDA) 8/4/09 Alert DOI: 10.1097/01.JDN.0000350433.54110.9c ISSN: 1945-760X Accession: 01412499-200909000-00002 Author(s): ...


FDA alters label of TNF blockers to include warnings of reported cases of leukemia in adults, adolescents and children and malignancies in children and adolescents


These cases are from various disease states and agents. We are awaiting specifics regarding each case anticipating that they will provide additional information for clinical decision making regarding the care and counseling of patients, both pediatric and adult, and their families with moderate to severe psoriasis. Meanwhile, this new warning should be addressed in context with patients on, or considering, TNF agents.


For more information on the FDA announcement:


Web Page Title: FDA: Cancer Warnings Required for TNF Blockers


Web Page URL:


For more information on the FDA announcement for healthcare professionals, including a summary of the data on which it was based:


Web Page URL:


Melodie S. Young, MSN, RN, ANP-c